216 related articles for article (PubMed ID: 32627141)
1. A pursuit of Staphylococcus aureus continues: a role of persister cells.
Chang J; Lee RE; Lee W
Arch Pharm Res; 2020 Jun; 43(6):630-638. PubMed ID: 32627141
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease.
Conlon BP
Bioessays; 2014 Oct; 36(10):991-6. PubMed ID: 25100240
[TBL] [Abstract][Full Text] [Related]
3. Molecular reprogramming and phenotype switching in
Huemer M; Mairpady Shambat S; Bergada-Pijuan J; Söderholm S; Boumasmoud M; Vulin C; Gómez-Mejia A; Antelo Varela M; Tripathi V; Götschi S; Marques Maggio E; Hasse B; Brugger SD; Bumann D; Schuepbach RA; Zinkernagel AS
Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33574060
[No Abstract] [Full Text] [Related]
4. The Toxin-Antitoxin MazEF Drives Staphylococcus aureus Biofilm Formation, Antibiotic Tolerance, and Chronic Infection.
Ma D; Mandell JB; Donegan NP; Cheung AL; Ma W; Rothenberger S; Shanks RMQ; Richardson AR; Urish KL
mBio; 2019 Nov; 10(6):. PubMed ID: 31772059
[No Abstract] [Full Text] [Related]
5.
Theis TJ; Daubert TA; Kluthe KE; Brodd KL; Nuxoll AS
Front Cell Infect Microbiol; 2023; 13():1178526. PubMed ID: 37228667
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-Produced Peroxynitrite Induces Antibiotic Tolerance and Supersedes Intrinsic Mechanisms of Persister Formation.
Beam JE; Wagner NJ; Shook JC; Bahnson ESM; Fowler VG; Rowe SE; Conlon BP
Infect Immun; 2021 Sep; 89(10):e0028621. PubMed ID: 34097475
[TBL] [Abstract][Full Text] [Related]
7. EttA is likely non-essential in Staphylococcus aureus persistence, fitness or resistance to antibiotics.
Meir M; Rozenblit A; Fliger S; Geffen Y; Barkan D
BMC Microbiol; 2020 Sep; 20(1):288. PubMed ID: 32943007
[TBL] [Abstract][Full Text] [Related]
8. Environmental Stress Affects the Formation of Staphylococcus aureus Persisters Tolerant to Antibiotics.
Kubistova L; Dvoracek L; Tkadlec J; Melter O; Licha I
Microb Drug Resist; 2018 Jun; 24(5):547-555. PubMed ID: 28813617
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic tolerance and the alternative lifestyles of
Bui LM; Conlon BP; Kidd SP
Essays Biochem; 2017 Feb; 61(1):71-79. PubMed ID: 28258231
[No Abstract] [Full Text] [Related]
10. High persister cell formation by clinical
Liu L; Wang Y; Bojer MS; Andersen PS; Ingmer H
Microbiology (Reading); 2020 Jul; 166(7):654-658. PubMed ID: 32427093
[TBL] [Abstract][Full Text] [Related]
11. msaABCR operon is involved in persister cell formation in Staphylococcus aureus.
Sahukhal GS; Pandey S; Elasri MO
BMC Microbiol; 2017 Nov; 17(1):218. PubMed ID: 29166860
[TBL] [Abstract][Full Text] [Related]
12. Future strategies for treating Staphylococcus aureus bloodstream infections.
Naber CK
Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():26-34. PubMed ID: 18226087
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic tolerance in biofilm persister cells of Staphylococcus aureus and expression of toxin-antitoxin system genes.
Karimaei S; Kazem Aghamir SM; Foroushani AR; Pourmand MR
Microb Pathog; 2021 Oct; 159():105126. PubMed ID: 34384900
[TBL] [Abstract][Full Text] [Related]
14. Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.
Rowe SE; Beam JE; Conlon BP
Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33526569
[TBL] [Abstract][Full Text] [Related]
15. [The prevalence of antiseptic resistance genes (qacA/B and smr) and antibiotic resistance in clinical Staphylococcus aureus strains].
Nakipoğlu Y; Iğnak S; Gürler N; Gürler B
Mikrobiyol Bul; 2012 Apr; 46(2):180-9. PubMed ID: 22639307
[TBL] [Abstract][Full Text] [Related]
16.
Nasser A; Jahanbakhshi S; Soltan Dallal MM; Banar M; Sattari-Maraji A; Azimi T
Curr Pharm Biotechnol; 2023; 24(15):1898-1915. PubMed ID: 37055886
[TBL] [Abstract][Full Text] [Related]
17. Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure.
Haaber J; Friberg C; McCreary M; Lin R; Cohen SN; Ingmer H
mBio; 2015 Jan; 6(1):. PubMed ID: 25587013
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of genes expression involved in type II toxin-antitoxin system in Staphylococcus aureus following persister cell formation.
Karimaei S; Aghamir SMK; Pourmand MR
Mol Biol Rep; 2024 Feb; 51(1):324. PubMed ID: 38393536
[TBL] [Abstract][Full Text] [Related]
20.
Gunn NJ; Kidd SP; Solomon LB; Yang D; Roscioli E; Atkins GJ
Front Cell Infect Microbiol; 2024; 14():1403289. PubMed ID: 38915921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
